MREO MREO
Company Profile ↓Company Overview
MREO (MREO) is a publicly traded company listed on with a market capitalization of $238.70M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -81.72% |
| 6 Months: | -28.08% |
| 3 Months: | +8.78% |
| 1 Month: | -9.40% |
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)47.05 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 86.9% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 9.00M | 0 | 0 | 0 | 0 | - | 500.00K | 0 | - |
| Operating Income | -11.41M | -811.00K | -9.07M | -9.90M | -12.81M | -9.37M | -11.20M | -10.50M | -10.02M | -8.77M |
| Net Income | -12.08M | -1.75M | -6.53M | -8.95M | -12.26M | -15.00M | -12.89M | -14.62M | -7.02M | -6.72M |
| Diluted EPS | -0.02 | 0.00 | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 |
| R&D Expense | 5.31M | 3.71M | 3.59M | 3.99M | 4.95M | 3.17M | 3.93M | 5.37M | 4.27M | 4.75M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 0 | 10.00M | 0 | 500.00K |
| Operating Income | -54.43M | -28.42M | -47.36M | -40.11M |
| Net Income | -42.22M | -29.47M | -43.25M | -41.88M |
| Diluted EPS | -0.07 | -0.04 | -0.06 | -0.05 |
| R&D Expense | 29.46M | 17.42M | 20.93M | 17.77M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 77.41M | 66.50M | 76.39M | 45.92M |
| Current Assets | - | 75.20M | 63.76M | 74.76M | 45.02M |
| Cash & Equivalents | - | 68.18M | 57.42M | 69.80M | 40.99M |
| Inventory | - | - | - | - | - |
| Receivables | - | 2.75M | 3.73M | 3.25M | 1.98M |
| Total Liabilities | - | 26.01M | 15.96M | 15.42M | 5.00M |
| Current Liabilities | - | 24.38M | 9.49M | 13.85M | 4.30M |
| Long Term Debt | 19.41M | - | 4.39M | - | - |
| Total Debt | - | 15.37M | 5.95M | 6.43M | 202.00K |
| Total Equity | - | 51.40M | 50.54M | 60.97M | 40.92M |
| Shares Outstanding | - | 624.93M | 701.22M | 775.73M | 795.66M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating Cash Flow | -48.82M | -21.13M | -32.83M | -30.97M |
| Investing Cash Flow | 1.99M | -419.00K | -699.00K | -20.00K |
| Financing Cash Flow | 200.00K | 7.97M | 46.15M | 327.00K |
| Capital Expenditure | -13.00K | -0 | -0 | -20.00K |
| Free Cash Flow | -48.83M | -21.13M | -32.83M | -30.99M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | - | - | - | - |
| Operating Margin % | - | -284.2% | - | -8,021.4% |
| Net Margin % | - | -294.7% | - | -8,375.6% |
| ROE % | -82.1% | -58.3% | -70.9% | -102.4% |
| ROCE % | -102.6% | -49.8% | -75.7% | -96.4% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for MREO
European Equities Traded in the US as American Depositary Receipts Track Sharply Higher in Thursday Trading
European equities traded in the US as American depositary receipts were tracking sharply higher late
European Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading
European equities traded in the US as American depositary receipts were tracking lower late Thursday
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
European equities traded in the US as American depositary receipts were tracking modestly higher lat
European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading
European equities traded in the US as American depositary receipts were trending higher late Monday
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
European equities traded in the US as American depositary receipts were lower late Wednesday morning
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
European equities traded in the US as American depositary receipts were sharply higher late Wednesda
MREO — Frequently Asked Questions
What is the current share price of MREO?
As of 2026-08-05 17:25 PDT, MREO trades at $0.30 on NASDAQ/NYSE. Its 52-week range is $0.24 to $2.31.
What is the market capitalisation of MREO?
MREO has a market capitalisation of $238.70M on NASDAQ/NYSE.
What is the P/E ratio of MREO?
MREO trades at a trailing price-to-earnings (P/E) ratio of -6.00. Its price-to-book (P/B) ratio is 5.84.
What is the return on equity (ROE) of MREO?
MREO has a return on equity (ROE) of -102.35%. Its return on capital employed (ROCE) is -96.38%.
Is MREO a good stock to buy?
This page provides a data-driven analysis of MREO, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.